180 likes | 195 Views
This article discusses the design and optimization of a tune-stabilized, linear-field FFAG accelerator for medical applications, focusing on the advantages and features of this type of accelerator for carbon therapy. The article also compares it to other accelerator principles and presents preliminary designs and goals for medical accelerators.
E N D
f Fermilab Tune-stabilized, Linear-field Nonscaling FFAG Lattice Design C. Johnstone, Fermilab S. Koscielniak, TRIUMF FFAG07 April 12-17, 2007 LPSC, Grenoble, France
f Applying the FFAG to Medical Reseach and Treatment Fermilab • Muon accelerators have been optimized for: • High, Multi-GeV acceleration energy • Minimal apertures for Superconducting magnets • Rapid acceleration for short-lived muons • Minimize change in TOF or revolution frequency • Medical accelerators require different optimization • Modest, 400 MeV/nucleon • Normal conducting magnets, so aperture is not a critical cost • Slow acceleration cycle • Conventional, low-power, low-cost rf acceleration system • The rf system can adapt to acceleration time structure of the beam • Magnetic fields which can control known beam instabilities
f Fermilab Applying the FFAG to Medical Reseach and Treatment • Emphasis in muon accelerators has been in stabilizing the revolution time for the beam • Emphasis in Medical accelerators is on stable optics, maintaining a constant machine tune over a large energy range Controlling optics and/or machine tune leads to the following candidates for medical accelerators:
f Fermilab Advances in Medical FFAG accelerators • Scaling FFAGs – being developed in Japan • Nonscaling FFAGs • Adjusted field profile (ADJ) • Brookhaven National Lab, nonlinear fields, dynamic aperture concerns • Tune-stablized, linear-field FFAG • Currently under patent process at Fermilab
f Tune-stablized, Linear-field FFAG for medical applications Fermilab Technical Abstract A hybrid design for a FFAG has been invented which uses a combination of edge and alternating-gradient focusing principles applied in a specific configuration to a combined-function magnet to stabilize tunes through an acceleration cycle which extends over a factor of2-6 in momentum. Previous work on fixed-field alternating gradient (FFAG) accelerators have required the use of strong, high-order multipole fields to achieve this effect necessitating complex and larger-aperture magnetic components as in the radial or spiral sector FFAGs. Using normal conducting magnets, the final, extracted energy from this machine attains 400 MeV/nucleon and thus supports a carbon ion beam in the energy range of interest for cancer therapy. Competing machines for this application include a superconducting cyclotron and a synchrotron. The machine proposed here has the high current advantage of the cyclotron with the smaller radial aperture requirements that are more typical of the synchrotron; and as such represents a desirable innovation for therapy machines.
f Tune-stablized linear-field nonscaling FFAG – general constraints Fermilab • FODO cell – for ease of solving linear equations • Peak fields are constrained to 1.5 T to avoid superconducting elements • Minimum rf drift imposed: 0.5 m • 400 MeV/nucleon imposed as the extraction energy • A set of coupled equations were developed and solved • Technical choices were made • Apertures • Fields • Constraints such as geometric closure of orbits were imposed
f Fermilab An example of how edge focusing is applied is given in the example below - a horizontally-focusing sector magnet with edge angles .
f Ring components Fermilab • Conventional normal-conducting magnets • Combined-function – constant (dipole) + linear-field (quadrupole) magnets • Peak fields of 1.5 T • Solid cores • Not expensive, complex laminated magnets as in pulsed synchrotrons • Reasonable parameters • 1 m apertures • Lengths ~ 0.5 – 1m
f Fermilab General Ring Parameters
Extraction reference orbit Injection reference orbit f Fermilab Comparison of muon vs. medical accelerator principles • Diagram of medical acceleration module
Extraction reference orbit Injection reference orbit f Comparison of muon vs. medical accelerator principles Fermilab • Diagram of muon acceleration module
f Dependence of cell tune on momentum:Preliminary design Fermilab In the legend, approx means the solution obtained from the approximated equations and model means the tune as modeled in MAD using these solutions
f Dependence of cell tune on momentum, muon FFAG Fermilab
f Preliminary Tracking: horizontal4,000 turns @ injection Fermilab
f Preliminary Tracking: vertical4,000 turns @injection Fermilab
f Goals of FFAG designs for Medical Accelerators Fermilab • Ultimate design consistent with carbon therapy • Preliminary lattices capable of 400 MeV/nucleon • 10-20 mm-mr normalized acceptance – not yet optimized • Synchrotron-like features • Variable extraction energy • Low losses and component activation • Multiple extraction points – multiple treatment areas • Normal conducting, no superconducting components requiring cryogenic facility • Cyclotron-like features • High current output • Ease of operation – no pulsed components or supplies • Scale-able to a 40-100 MeV/nucleon prototype
f Fermilab Fermilab’s Plans for R&D of Medical Accelerators • Immediate • U.S./DOE patent • Full simulation requires code upgrades • Magnet specifications and design • Near future • Research and Industrial partners • Preferably an international partner • Pursue a EU or international patent • Technology Transfer to industrial partners • Fermilab can contribute a large portion of R&D in terms of technical design, labor, and prototypes on all aspects of the project including diagnostics and eventual commissioning of a prototype machine
f Fermilab Possible Timescale for Medical Accelerator Development • May, 2006 • Provisional US patent • Nondisclosure agreements – still available • June, 2006 • Public release of preliminary information at EPAC06 • June, 2007 • US patent • Identify research and industrial partners • R&D plan in place • Spring, 2008 • Conceptual Design